Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 38 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

38 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Sept. 3, 2021 CLRB P 19,417 $1.04 $20,194 19,417 Direct · Acquired -99.4% (price as of 2026-10-02)
Feb. 23, 2021 LITS S 25,000 $4.03 $100,750 37,500 Direct -40.00% Disposed -98.3% (price as of 2026-10-02)
Aug. 11, 2020 IBRX S 5,300 $10.77 $57,081 109,235 Direct -4.63% Disposed -4.5% (price as of 2026-10-02)
Aug. 11, 2020 IBRX S 10,000 $9.98 $99,800 114,535 Direct -8.03% Disposed 3.1% (price as of 2026-10-02)
Aug. 11, 2020 IBRX S 50,000 $10.22 $511,000 124,535 Direct -28.65% Disposed 0.6% (price as of 2026-10-02)
Dec. 19, 2019 LITS P 62,500 $1.60 $100,000 62,500 Direct · Acquired -95.7% (price as of 2026-10-02)
Aug. 9, 2011 NVAX P 20,000 $1.18 $23,600 20,000 Direct · Acquired -55.7% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
July 7, 2026 CLRB Stock option (right to buy) Common stock (25,000) $2.70 July 7, 2036 25,000 Acquired
Nov. 14, 2025 LITS Stock Option (Right to Buy) Common Stock (55,000) $2.02 Nov. 14, 2035 55,000 Acquired
July 15, 2025 LITS Stock Option (Right to Buy) [F1] Common Stock (20,000) $3.07 July 15, 2035 20,000 Acquired
Feb. 14, 2025 CLRB Stock option (right to buy) Common Stock (60,000) $0.29 Feb. 14, 2035 60,000 Acquired
Jan. 2, 2025 CUE Stock Option (right to buy) Common Stock (24,400) $1.09 Jan. 1, 2035 24,400 Acquired
June 14, 2024 CLRB Stock option (right to buy) Common Stock (60,000) $2.58 Dec. 22, 2033 60,000 Acquired
Jan. 2, 2024 CUE Stock Option (right to buy) Common Stock (24,400) $2.78 Jan. 1, 2034 24,400 Acquired
Sept. 29, 2023 LITS Stock Option (Right to Buy) Common Stock (10,000) $7.01 Sept. 29, 2033 10,000 Acquired
June 28, 2023 CLRB Stock option (right to buy) Common Stock (25,000) $1.85 June 28, 2033 25,000 Acquired
Jan. 3, 2023 CUE Stock Option (right to buy) Common Stock (10,000) $2.66 Jan. 2, 2033 10,000 Acquired
July 5, 2022 LITS Stock Option (Right to Buy) Common Stock (87,500) $0.54 July 5, 2032 88 Acquired
June 24, 2022 CLRB Stock option (right to buy) Common Stock · June 24, 2032 7,800 Acquired
Jan. 3, 2022 CUE Stock Option (right to buy) Common Stock (10,000) $12.28 Jan. 2, 2032 10,000 Acquired
July 1, 2021 LITS Stock Option (Right to Buy) Common Stock (50,000) $2.95 July 1, 2031 50,000 Acquired
June 30, 2021 CLRB Stock option (right to buy) Common Stock (78,000) $1.19 June 30, 2031 78,000 Acquired
Jan. 4, 2021 CUE Stock Option (right to buy) Common Stock (10,000) $12.36 Jan. 3, 2031 10,000 Acquired
July 2, 2020 LITS Stock Option (Right to Buy) Common Stock (50,000) $3.49 July 2, 2030 50,000 Acquired
June 24, 2020 CLRB Stock option (right to buy) Common Stock (50,000) $1.28 June 24, 2030 50,000 Acquired
June 10, 2020 IBRX Stock Option (right to buy) Common Stock (100,000) $6.21 June 10, 2030 100,000 Acquired
Jan. 2, 2020 CUE Stock Option (right to buy) Common Stock (8,000) $16.31 Jan. 2, 2030 8,000 Acquired
July 1, 2019 LITS Stock Option (Right to Buy) Common Stock (40,000) $2.52 July 1, 2029 40,000 Acquired
June 13, 2019 CLRB Stock option (right to buy) Common Stock (6,500) $2.15 June 13, 2029 6,500 Acquired
Jan. 2, 2019 CUE Stock Option (right to buy) Common Stock (8,000) $5.16 Jan. 2, 2026 8,000 Acquired
Oct. 12, 2018 CLRB Stock option (right to buy) Common Stock (13,000) $2.61 Oct. 12, 2028 13,000 Acquired
July 12, 2018 LITS Stock Option (Right to Buy) Common Stock (40,000) $4.28 July 12, 2028 40,000 Acquired
June 26, 2018 CUE Stock Option (right to buy) Common Stock (50,000) $12.97 June 26, 2025 50,000 Acquired
Feb. 22, 2018 LITS Options to purchase shares of common stock Common Stock, par value $0.00000002 per share (33,333) $2.19 Feb. 22, 2028 33,333 Acquired
May 31, 2017 CLRB Stock option (right to buy) Common Stock (10,000) $1.74 May 31, 2027 10,000 Acquired
March 2, 2013 NVAX Options-right to buy Common Stock (150,000) $1.83 March 2, 2023 150,000 Acquired
March 1, 2012 NVAX Options-right to buy Common Stock (150,000) $1.28 March 1, 2022 150,000 Acquired
March 10, 2011 NVAX Options-right to buy Common Stock (150,000) $2.50 March 10, 2021 150,000 Acquired
April 15, 2010 NVAX Options-right to buy Common Stock (30,000) $2.66 April 15, 2020 30,000 Acquired
March 15, 2010 NVAX Options-right to buy Common Stock (30,000) $2.35 March 15, 2020 30,000 Acquired
Aug. 24, 2009 NVAX Stock Option (Right to buy) Common Stock (220,000) $5.21 Aug. 24, 2019 220,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 2 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
June 27, 2018 CUE No securities are beneficially owned 0 Direct
Feb. 26, 2018 LITS Common Stock 0 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2013 $115,530 · · $150,000 · · $46,442 $311,972
2012 $296,605 · · $102,165 $95,522 · $2,543 $496,835
2010 $277,941 · · $99,936 $84,539 · $4,781 $467,197

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.